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Protein–membrane interactionThe human immunodeﬁciency virus type 1 (HIV-1) p6 protein has recently been recognized as a docking site for
several cellular and viral binding partners and is important for the formation of infectious viruses. Most of its
known functions are suggested to occur under hydrophobic conditions near the cytoplasmic membrane,
where the protein is presumed to exist in its most structured state. Although p6 is involved in manifold speciﬁc
interactions, the protein has previously been considered to possess a random structure in aqueous solution. We
show that p6 exhibits a deﬁned structure with N- and C-terminal helical domains, connected by a ﬂexible hinge
region in 100 mMdodecylphosphocholine micelle solution at pH 7 devoid of any organic co-solvents, indicating
that this is a genuine limiting structural feature of themolecule in a hydrophobic environment. Furthermore, we
show that p6 directly interactswith a cytoplasmicmodelmembrane through bothN-terminal and C-terminal re-
gions by use of surface plasmon resonance (SPR) spectroscopy. Phosphorylation of Ser-40 located in the center of
the C-terminal α-helix does not alter the secondary structure of the protein but ampliﬁes the interaction with
membranes signiﬁcantly, indicating that p6 binds to the polar head groups at the surface of the cytoplasmic
membrane. The increased hydrophobic membrane interaction of p623-52 S40F correlated with the observed in-
creased amount of the polyprotein Gag in the RIPA insoluble fraction when Ser40 of p6 was mutated with Phe
indicating that p6 modulates the membrane interactions of HIV-1 Gag.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
The human immunodeﬁciency virus type 1 (HIV-1) p6 protein
serves manifold functions as a docking site for several cellular and
viral factors and fulﬁls important roles in the formation of infectious
virus particles. It facilitates virus budding [1–3] through functioning
of two distinct late assembly (L-) domains and is required for the in-
corporation of the viral accessory protein viral protein R (Vpr) into
virus particles [4–7]. In addition, p6 is the major phosphoprotein of
HIV-1 particles as Ser, Thr, and Tyr residues within p6 serve as a sub-
strate for virion associated kinases [8]. One of the potential phosphor-
ylation sites in p6 is a highly conserved Ser residue in position 40, a
residue we recently described to be important for the infectivity of
the released virions by affecting capsid maturation and virus core for-
mation [9]. The functional importance of phosphorylation of residuesC, Dodecylphosphatidylcholine;
ate assembly domains; NMR, nu-
ffect Spectroscopy; SPR, surface
y; Tsg101, tumor susceptibility
47 55589490.
.
l rights reserved.within p6 has not been elucidated. However, the fact that several
other viral proteins harboring late domains have also been described
as phosphoproteins and may indicate a functional role in connection
with budding events in the viral life cycle [8].
The identiﬁed functions of HIV-1 p6 are likely to occur in proximity
to the plasma membrane of the cells. Recently, Salgado et al. suggested
that HIV-1 p6 directly interacts withmembranes with high afﬁnity, and
thereby is absorbed into the surface of the cytoplasmic membrane
where the proteinmaymanage some of its interactions including bind-
ing to Vpr [10,11]. The hydrophobic environment near or inside a
membrane would be expected to inﬂuence the structure of p6.We pre-
viously determined the secondary structure of the full-length synthetic
protein (sp6) by nuclear magnetic resonance (NMR) spectroscopy in a
50% aqueous TFE solution, which is considered to mimic the hydropho-
bic conditions in proximity to a membrane [12]. Under these solution
conditions, sp6 adopts a helix-ﬂexible helix structure; a short helix-1
(residues 14–18) is connected to a pronounced helix-2 (residues
33–44) by a ﬂexible hinge region, which has been supported by recent
theoretical calculations [13].
Although the functional domains of p6 appear to be well correlated
with the locations of α-helical domains, the validity of the structure of
p6, determined in 50% aqueous TFE at pH 3, under physiological
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perties of TFE [10]. However, new experimental structural data on
full-length sp6 in alternative membranous solution conditions (mi-
celles, etc.) were not attempted. HIV-1 p6 has previously been consid-
ered to exhibit a random structure in aqueous solution [14,15],
though no detailed structural investigations using 2D NMR have been
performed to support this assumption.
To explore the validity of the secondary structure of full-length
HIV-1 sp6 under physiological conditions, we performed 2D NMR
experiments of synthetic full-length p6 and N- and C-terminal frag-
ments thereof in aqueous solution at physiological pH, in the pres-
ence and absence of DPC-D38 micelles. Furthermore, we investigated
the direct interaction of HIV-1 p6 with cytoplasmic membranes and
the inﬂuence of phosphorylation on this interaction by the use of sur-
face plasmon resonance (SPR) spectroscopy.
2. Materials and methods
2.1. Peptide synthesis
Synthesis, puriﬁcation and molecular characterization of synthetic
full-length p61-52 (sp61-52) and its fragments sp61-21 and sp623-52
were performed as described in detail elsewhere [12,16].
Synthesis of sp623-52 phosphorylated at Ser 40 and sp623-52 S40Fwas
performed by stepwise solid-phase synthesis of the peptide acid on an
automated ABI 433A peptide synthesizer from Applied Biosystems on
a 0.1 mM scale, using conventional Fmoc/tBu strategy (HBTU, DIEA,
NMP). As solid support preloaded H-Gln(Trt)-HMPB-ChemMatrix
resin (100 mg, loading 0.47 mmol/g) from PCAS BioMatrix Inc. was
used. All amino acids were coupled according to standard methodolo-
gies in an automated single or double couplingmode. For the phosphor-
ylated S-40N-α-Fmoc-O-benzyl-L-phosphoserine from Novabiochem
was used. Fmoc deprotection was carried out with 20% piperidine in
NMP. Cleavage of crude peptides from their resins was accomplished
through treatmentwith 95% TFA 2.5%water, 2.5% TIPS for 3.5 h. Prepar-
ative puriﬁcation by high-pressure liquid chromatography (HPLC) was
carried out on a Shimadzu LC-8A system with a Agilent Prep-C18
(250x30mm) column (Buffer A: 0.2% TFA in water, Buffer B: 0.2% TFA
in water: acetonitrile, 1:4). The puriﬁed peptides were dried by lyophi-
lization and characterized by analytical HPLC and mass spec analysis.
2.2. Mass spectrometry
Matrix assisted laser desorption ionizationmass spectra (MALDI-MS)
were recorded on a Voyager-DE PRO BioSpectrometryWorkstation from
Applied Biosystems. Samples were dissolved in 50% aqueous acetonitrile
and α-cyano-4-hydroxycinnamic acid was used as matrix. Positive ion
electrospray ionization mass spectra (ESI-MS) were recorded on a
Micromass Q-Tof-2 mass spectrometer. Samples were dissolved in 70%
aqueous methanol and infused into the electrospray chamber with a
needle voltage of 0.9 kV, at a ﬂow rate of 40 nl/min.
2.3. NMR spectroscopy
1D and 2D 1H NMR experiments (Total Correlation Spectroscopy
(TOCSY) and Nuclear Overhauser Effect Spectroscopy (NOESY)) were
performed at 600.13 MHz on a Bruker Avance 600 MHz instrument
equipped with an UltraShield Plus magnet and a triple resonance cryo-
probe with gradient unit. Individual samples were dissolved in either
(1) 600 μl water containing 10% D2O (v/v) at pH 3, (2) 600 μl 50 mM
aqueous phosphate buffer pH 7.0 containing 10% D2O (v/v) or (3)
600 μl 50 mM aqueous phosphate buffer pH 7.0 containing 10% D2O
and 100 mM DPC-D38, at concentrations between 1 and 2 mM. The 2D
NMR experiments were performed at 300 K without spinning with
mixing times of 110 ms for the TOCSY experiments and 250 ms for the
NOESY experiments, respectively. Efﬁcient suppression of the watersignal was achieved by application of excitation sculpting in the 1D and
2D NMR experiments [17]. 1H signal assignments of the NMR spectra
were achieved by identiﬁcation of the individual spin systems in the
2D 1H TOCSY spectra, combined with observations of sequence-speciﬁc
short-distance cross peaks (Hα−HN i, i+1) in the 2D 1H NOESY spectra
[18,19]. Readily recognisable spin systems were used as starting points
for correlation of the individual spin systems observed in the TOCSY
and NOESY spectra to individual residues in the peptide sequences. Ac-
quisition of data, processing and spectral analysis were performed with
Bruker Topspin 1.3 software. Assigned 1H chemical shifts of p6 and pep-
tides are presented in Tables A.1–A.10 of the Supplementary data. The
conformational shifts were calculated using the random-coil values
reported by Wüthrich [18,19].
2.4. Structure calculation
The 1H TOCSY and NOESY spectra of p623-52 with Ser40 phosphory-
lated were processed using CCP NMR Analysis version 2.1.5 [20]. Dis-
tances were derived from NOE peak heights in the 1H-1H NOESY
spectrum and structure calculations were performed by using CYANA
2.1[21].
2.5. Unilamellar vesicles preparation
Liposomes were produced from egg phosphatidylcholine (PC), egg
phosphatidyl ethanolamine (PE), bovine brain phosphatidylserine
(PS), bovine liver phosphatidylinositol (PI), phosphatidic acid (PA),
heart cardiolipin (CL) and brain sphingomyelin (SM) togetherwith cho-
lesterol (Ch). Phospholipids and cholesterol were dissolved in chloro-
form at a concentration of 10 mg/ml. PC or the appropriate proportion
of phospholipids mimicking the cytoplasmic membrane andmitochon-
drial membrane [22] were mixed to a total lipid content of 25 mg. The
following composition of anionic liposomes (mol%) were applied:
Cytoplasma membrane: 39% PC, 23% PE, 9% PS, 8% PI, 1% PA, 1% CL, 1%
SM and 18% Chol, respectively. Outer mitochondrial membrane: 50%
PC, 31% PE, 1.8% PS, 7.7% PI and 9.5% CL, respectively [22]. The solution
was dried under a stream of nitrogen to give lipid ﬁlms and residual
chloroform was removed under vacuum (2 hour). The lipid ﬁlm were
re-suspended in 50 mM PBS buffer pH 7.4 (1 mg lipid per ml) and hy-
drated over night at 37 °C. The liposomes were then subjected to
seven freeze-thaw cycles using sequentially liquid N2 and a water
bath at 55 °C. Finally, extrusions through two 100 nm Millipore ﬁlters
were performed 7 times in order to produce unilamellar vesicles of ho-
mogenous size. The sizes of the unilamellar vesicles were analyzed
using dynamic light scattering, yielding a narrow size-distribution
with maximum at 90–100 nm.
All phospholipids used for producing the unilamellar vesicles
were purchased from Avanti Polar Lipids, Alabama, USA, while cho-
lesterol (Ch) was bought from Sigma Aldrich, Germany.
2.6. SPR spectroscopy
SPRmeasurementswere performed at 25 °C on a Biacore T200 instru-
ment (Biacore AB, Uppsala, Sweden). Prior to immobilization ﬂow cell
surfaces were preconditioned with two times 30 sec injection of
isopropanol:50 mM NaOH (2:3) at ﬂow rate 10 μL per min, followed by
30 sec injection 40 mM 3-[(3-cholamidopropyl)-dimethylammonia]-1-
propan-sulfonate (CHAPS). Liposomes were captured onto L1 research-
grade sensor chip surfaces by injecting liposome solution (concentration
between 0.6 and 1 mM) using low ﬂow rates of 10 μL/min to approxi-
mately 5000 RU (capture contact time 60 sec). Regeneration of the chip
surface isopropanol:50 mM NaOH (2:3) was performed between each
run. The p6 peptides were dissolved in the running buffer (HBS-EP buffer
pH 7.4; 10 mM HEPES, 150 mM NaCl, 3.4 mM EDTA and 0.005%
surfacant) and injected at various concentrations ranging from 10 to
600 μM containing duplicate of one concentration at a ﬂow rate of
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2.5 Hz during 60 s association and 300 s dissociation phases, and the
sensorgrams were corrected for unspeciﬁc signals by subtraction of the
reference buffer curves. Visual analysis of the sensorgrams indicated a rel-
atively weak interaction (rapid association and rapid dissociation), why
steady state afﬁnity analyzes of the SPR data was performed to derive
afﬁnity constants. The analysis was performed by plotting concentration
versus response maximum for each concentration injected, and the
curves were ﬁtted to a one site saturation binding model using the
GraphPad Prism software for Mac versions 5.0d–f.
Western blot analysis of transfected cells
For protein analyses by western blotting HeLa cells were tran-
siently transfected using Lipofectamine 2000™ (Invitrogen). 24 h
post transfection cells were lysed in ice cold RIPA buffer (50 mM
Tris–HCl pH 7.4, 150 mM NaCl, 1% NP-40, 0.5% sodium deoxycholate,
0.1% SDS, 5 mM EDTA, 1 mM PMSF, and complete protease inhibitor
cocktail (Boehringer)) and lysates were separated by centrifugation
at 20,000×g and 4 °C for 5 min. The supernatant was adjusted to
1% SDS and incubated for 5 min at 95 °C. The RIPA insoluble fraction
was solubilized by resuspending the pellet in RIPA buffer and then ad-
justed to 1% SDS. The lysates were incubated for 20 min at 95 °C and
subsequently cleared by centrifugation at 20,000×g and 4 °C for
10 min. The samples were separated by SDS PAGE [23] and blotted
onto PVDF membranes (GE Healthcare). Gag proteins were stained
with anti-p24 rabbit antiserum (Seramun).
3. Results and discussion
3.1. Structural assignment of sp6 peptides and full-length sp61-52 in
aqueous solution in the presence and absence of DPC micelles
Previous reports have indicated a random structure of p6 in aqueous
solution [10,12,14,15]. To determine the solution structure of p6 in a
hydrophilic environment, assignments of 1H chemical shifts of
full-length sp61–52 in addition to the N-terminal sp61–21 and the
C-terminal sp623–52 peptides were performed in aqueous solution at
pH 3 and pH 7.
The Hα chemical shift index of N-terminal sp61-21, C-terminal
sp623-52 and full-length sp61-52 showed that the secondary structure
of p6 is conserved, though weaker than the corresponding secondary
structure of sp6 in 50% aqueous TFE (Fig. 1 and Fig. A1–A2), where the
protein exhibits a helix-ﬂexible-helix structure consisting of a short
helix-1 (residues 14–18) connected to a pronounced helix-2 (residues
33–44) by a ﬂexible hinge region [12]. Moreover, comparison of the
Hα chemical shift indexes of sp61–21, sp623–52 and full-length sp61–52
in aqueous solution at pH 3 and pH 7 showed that this weak secondary
structure of p6 is conserved in aqueous solution at pH 7 (Fig. 1 and Fig.
A5 A–D). This was further supported by the observation of NH-NH (i,
i+1) cross peaks in the 2D 1H NOESY spectra of N-terminal sp61–21,
C-terminal sp623–52 and full-length sp61–52 recorded in aqueous solu-
tion. Thus, we have explored if p6 retains some secondary structure in
aqueous solution devoid of any detergent supplements. Under these so-
lution conditions the protein shows low concentrations of conformers
with α-helical structure in aqueous solution that exist along with
more prevalent random coil conformations of the protein (Fig. 1). The
localization of the α-helices is the same as determined for sp6 under
more hydrophobic solution conditions (Fig. 1), i.e. 50% aqueous TFE
[12]. In contrast to the behaviour of HIV-1 Vpr [18], the secondary struc-
tures of full-length sp6 and the N-terminal and C-terminal peptides
sp61–21 and sp623–52, respectively, are conserved in aqueous solution
ranging from pH 3 to pH 7 (Fig. 1).
The interaction of p6 with Vpr appears to be most signiﬁcant
under membranous conditions [11]. However, no detailed structural
data for full-length p6 under hydrophobic solution conditions devoidof organic co-solvent exist in the current literature. Hence we next in-
vestigated the behaviour of full-length sp6, as well as the N-terminal
and C-terminal peptides sp61–21 and sp623–52, in 100 mM aqueous
DPC micelle solution at pH 7 (Fig. 1 and Fig. A3). Under these solution
conditions, the secondary structure of p6 is similar to the structure as-
sumed by the protein in 50% TFE (Fig. 1) but better deﬁned. The
high-ﬁeld chemical shifts of the Hα of residues Glu12-Glu19 com-
pared to those of random coil residues (negative values in Fig. 1), in
addition to the observation of continuous NH-NH (i, i+1) cross
peaks from residues Glu12 to Glu20 in the 2D NOESY spectra (Fig.
A4) indicate that the N-terminal α-helix involves these residues.
Analogously, the negative values for residues Ile31–Leu35 and
Leu38–Phe45, in addition to the observation of continuous NH-NH
(i, i+1) cross peaks for residues Ile31–Tyr36 and Leu38–Asp48 in
the 2D NOESY spectra (Fig. A4–A5) indicate that the better deﬁned
and more extensive C-terminal α-helix includes these residues. In
addition, the observation of the cross peaks at 4.78/8.37 ppm corre-
sponding toHα-NH(i, i+3) Tyr36/Ala39, 4.78/1.47 ppmcorresponding
to Hα-Hβ(i, i+3) Tyr36/Ala39 and 3.69/8.37 ppm and 3.50/8.37 ppm
corresponding to Hδ-NH(i, i+2) Pro37/Ala39 indicate the presence of
a continuous C-terminal α-helix of full-length p6 including residues
Ile31–Phe45, which also involves residues Gly46-Asp48, and is equiva-
lent to the previously published structure of sp6 in 50% aqueous TFE at
pH 3 [12]. Salgado et al. [10] indicated that Pro37 may act as a
helix-breaker in the short C-terminal p6 peptide sp632–52 in micelle so-
lution. The discrepancy of these results compared with those from our
study may originate from the fact that this short C-terminal peptide
does not include all the residues constituting the C-terminal helix of
full-length sp6, hence the secondary structure of the short peptide
sp632–52 with an incomplete C-terminal helix may be more unstable
and less well deﬁned.
The N-terminal helical region of p6 incorporates a deﬁned binding
region of Vpr that is essential for Vpr packaging into the virion (Fig. 2)
[24]. The highly conserved N-terminal late-domain of p6 with the
PTAPmotif is not included in theα-helical region but is located adjacent
to helix-1 (Fig. 2). The helix may play an indirect role in the speciﬁc
complex formation between p6 and the binding groove of Tsg101, an
E2-type ubiquitin ligase-like protein [1,2,13,25–30]. The second
C-terminal YPXL late-domain of p6, incorporated in the extensive
C-terminal α-helix (Fig. 2), mediates the binding of p6 to ALG-2
interacting protein 1/X (ALIX), a class E vacuolar protein that also inter-
acts with tumor susceptibility gene 101 (Tsg101) [31]. X-ray crystallo-
graphic studies revealed that the L35YPxnLxxL41 motif of p6 is
required for ALIX-mediated virus budding and binds a region of ALIX
spanning residues 360–702, forming a topologically complex arrange-
ment of 11 α-helices comprising a 30 Å long hydrophobic pocket,
which is sufﬁciently long to incorporate the C-terminal α-helix of p6
[32–34]. The C-terminal helix of p6 also includes the L41XXLF45 motif
that has been reported to form the core of the binding region of p6 to
Vpr [4,35]. Recent reports [10,12] indicate a more extensive binding re-
gion of p6 to Vpr incorporated in the C-terminal helix, including the
same C-terminal L-domain L35YPxnLxxL41 motif that interacts with
ALIX [33,36].
3.2. HIV-1 p6 interacts directly with cytoplasmic model membrane
through both a N-terminal and a C-terminal region of the protein
Most of the known functions of p6 are suggested to occur in prox-
imity to the cellular cytoplasmic membrane. Previously, Salgado et al.
indicated a relatively strong interaction between an egg phosphati-
dylcholine (PC) bilayer model and both full-length HIV-1 p6 and a
short C-terminal peptide of p6 (p632-52) using plasmon waveguide
resonance (PWR). Theoretical MD simulations suggested that p6
may be adsorbed within the polar lipid head groups of the membrane
with some perturbation of the fatty acid chains caused by the direct
interaction of hydrophobic side chains residues [11]. However, these
Fig. 1. Chemical shift differences (ppm) of theα-protons between the experimental values and those for residues in a random coil for sp61–52 in aqueous solution at pH 3 (A) and pH
7 (B), in aqueous 100 mM DPC-d38 micelle solution at pH 7 (C) and in 50% aqueous TFE at pH 3 (D) at 300 K. All positive values for N-terminal residues adjacent to proline residues
at positions 5, 7, 10, 11, 24, 30, 37 and 49 arise from an inherent effect of proline and not out of a structural perturbation, as described in ref. [18].
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experimental data. To investigate the direct interaction of p6with cyto-
plasmic membrane in more detail we performed interaction studies by
SPR spectroscopy, a method found to be very successful for examining
peptide- or protein–membrane interactions [37,38]. To achieve a bestFig. 2. Structure of sp61–52 under hydrophobic conditions and its functional domains. In-
teraction regions with Tsg-101, Vpr and ALIX are highlighted. The helices shown are best
deﬁned for the residues Ser14–Gly18 (helix-1) and Ile31–Phe45 (helix-2), respectively,
but also to some extent involve Glu12 to Glu20 (helix-1) and Ile31–Asp48 (helix-2) [12].possible in vitro system for these experiments, we prepared a more
complex liposome bilayer containing the known components of a cyto-
plasmic membrane [22]. The composite cytoplasmic model membrane
was immobilised on a L1 sensor chip. The SPR sensorgrams of the inter-
action between C-terminal sp6 (p623–52) and the cytoplasmic model
membrane conﬁrmed an interaction between p6 and cytoplasmicmim-
icking membrane (Fig. 3). Steady state analysis is the most suitable
analysis to obtain afﬁnity constants of relatively weak interactions,
which is identiﬁable by very rapid association and dissociation phases.
By visual analysis of the sensorgram of sp623–52, it is uncertain whether
the highest concentration (250 μM) reaches at least 80% saturation,
which is a requirement for steady state afﬁnity analysis. To obtain an
exact afﬁnity constant, SPR sensorgrams of higher concentration
would have been desirable. However, a general problem for weaker in-
teractions is that this is not always obtainable due to aggregation and
solubility problems. Since KD is deﬁned as concentration at 50% satura-
tion, visual analysis clearly illustrate that the KD for sp623-52 is greater
than highest concentration tested (i.e. KD >250 μM) (Fig. 3, Table 1).
Fig. 3. A) SPR sensorgrams of sp6(23–52), sp6(1–21), sp6(23–52) S40 phosphorylated and the mutant sp6(23–52) S40F were analyzed for binding to immobilized cytoplasmic
model membranes (CM). The peptides were injected at various concentrations containing duplicates of each concentration over a L1 sensor chip immobilised with approximately
5000 RU cytoplasmic mimicking liposomes (phospholipid mixture of 39% PC, 23% PE, 9% PS, 8% PI, 1% PA, 1% CL, 1% SM and 18% Chol) B) Afﬁnity analysis of the SPR data were
performed plotting concentration versus response maximum for each concentration injected, and the curves were ﬁtted to a one site saturation binding model using the GraphPad
Prism software.
Table 1
Estimated kinetic constants for p6peptides interactingwith cytoplasmicmimicking liposome
bilayer immobilised on a sensor chip.
Peptide Immobilised Steady state afﬁnity
KD (μM)±SE
Rmax±SE
sp6(23–52) CM >250⁎ -
sp6(1–21) CM >250⁎ –
sp6(23–52)S40 phosph. CM 25±11 489±55
sp6(23–52) S40F CM 29±19 276±19
⁎ Exact steady state afﬁnity constants was not obtainable since saturation were not
reached at highest concentration tested.
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afﬁnity to the cytoplasmic membrane, similar experiments were per-
formed on the N-terminal peptide sp61–21. Indeed, N-terminal p6 also
interactedwith the cytoplasmicmodelmembrane (Fig. 3, Table 1). By vi-
sual analysis of obtained senorgrams, it is uncertain whether the highest
concentration (250 μM) reaches at least 80% saturation, however clearly
illustrate that the KD for sp61-21 is greater than highest concentration
tested (i.e. KD >250 μM) (Fig. 3, Table 1). These data demonstrates that
p6 is able to interact with cytoplasmic model membrane both through
N- and C-terminal regions.
Compared to the previously determined dissociation constants for
the C-terminal p6 peptide p632-52 and full-length p6 by PWR of
0.056 μM and 0.034 μM respectively [11], our results suggest a signif-
icantly weaker binding to the membrane. To investigate the potential
inﬂuence of the more complex liposome bilayer model cytoplasmic
membrane, we also immobilized the simple liposome bilayer pro-
duced from only PC. These experiments showed a similar afﬁnity of
p6 to the simple liposome bilayer model as the more complex cyto-
plasmic model membrane (Fig. A5). Similar experiments performed
using a composite mitochondrial model membrane showed a similar
afﬁnity to p6 peptides (Fig. A5). In summary, the binding data here
obtained for p6 peptides with several model membranes includingthe simple PC bilayer and more complex membranes were very sim-
ilar (Fig A5) but signiﬁcantly weaker than those previously reported
by Salgado et al. [11]. However, the results presented in the current
paper are in agreement with an interaction of p6 restricted to the
membrane surface. It is difﬁcult to evaluate the data for the interac-
tion of p6 with PC bilayers given in Salgado et al. [11], as the authors
do not provide any PWR spectra or plots of resonance position shift
for these interactions. The only documentation offered for this inter-
action by Salgado et al. is some tabulated values which are not further
detailed neither in textual nor in diagrammatic form in their article. It
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of p6 interaction with membrane compared to our results.
3.3. Inﬂuence of phosphorylation of Ser40 on the interaction with model
cytoplasmic membranes
One of the potential phosphorylation sites in p6 is a highly con-
served Ser residue in position 40, a residue we recently found to be im-
portant for the infectivity of the released virions through changes in
capsid maturation and virus core formation [9]. The budding events,
in which p6 is involved, occur near the cytoplasmic membrane, which
makes a potential inﬂuence of phosphorylation of Ser40 of p6 on the
direct interaction with the cytoplasmic membrane of interest. The
3-dimensional structure of sp623–52 phosphorylated at Ser40was deter-
mined by 2D NMR spectroscopy at atomic resolution (Fig. 4, Structural
statistics Table A11). Phosphorylation of a residue (Ser, Thr or Tyr) lo-
cated at the center of a α-helix often leads to disruption of the
α-helical structure due to introduction of a charged group in a hydro-
phobic structural element [39–41]. It was thus our expectation that
this ﬁnding would be mirrored in the current case. However, the sec-
ondary structure was conserved upon phosphorylation of Ser-40 locat-
ed at the center of the C-terminal α-helix of p6. A few exceptions exist
in current literature where the α-helical structure could be conserved
or even enhanced when a residue becomes phosphorylated which cor-
roborate our ﬁndings [42]. Although Ser40 is located at the centre of the
C-terminal helix of p6, phosphorylation of this residue did not disrupt
the helical structure in this region (Fig. 4, Fig. A6-A8) although the envi-
ronment of the neighbouring residues and those located 1–2 turns apart
in the helix were affected resulting in a downﬁeld shift effect of the Hα
chemical shifts of these residues (Fig. A9).
The potential inﬂuence of phosphorylation of Ser40 on interactions
of p6 with cytoplasmic membranes would offer valuable insight into
the nature of this interaction because the phosphoryl group introduces
a negative charge, increasing the ionic properties of the peptide al-
though the secondary structure of C-terminal p6 is conserved. Subse-
quently, the membrane-interacting properties of this peptide were
determined by SPR spectroscopy (Fig. 3 and Table 1). The steady state
afﬁnity analysis of the SPR sensorgram showed that phosphorylation
of Ser40 resulted in approximately 10 times increased binding afﬁnity
of C-terminal p6 to the cytoplasmic membrane compared with the wt
peptide (Fig. 3, Table 1).
To investigate if the sidechains of hydrophobic residues are able to
interact with the lipophilic tails of the membrane lipids, analogous ex-
periments were performed on the C-terminal mutant peptide sp623-52
S40F. This peptide shows the same localization and extent of secondary
structure to that of the wt peptide [9]. Indeed, the interaction with
model cytoplasmic membrane was to some extent ampliﬁed by intro-
ducing this mutation (Fig. 3 and Table 1) indicating that hydrophobicSer-40 phosphorylated
Fig. 4. Structural calculation of sp623–52 S40 phosphorylated. The structural calculation
was performed using CYANA 2.1. The structure conﬁrms that the C-terminal α-helical
structure of sp6 is intact when S40 is phosphorylated.sidechains are able to interact with the lipophilic tails of the membrane
lipids in the upper layer of the cytoplasmic membrane. In summary, a
stronger interaction with membranes was achieved by increasing the
ionic properties of p6. Thus, it becomes evident that the protein binds
to the polar charged head groups at the membrane surface and is not
deeply absorbed into the membrane although sidechains of hydropho-
bic residues seem to be able to interact with the lipophilic tails of the
upper-layer membrane lipids.
The S40F mutation within p6 leads to an enhanced membrane association
of Gag in cells
p6 comprises the C-terminal of the polyprotein HIV-1 Gag. To inves-
tigate the impact of the S40F mutation on the intracellular distribution
of Gag, HeLa cells transfected with pΔR wt [43] or the p6 S40F mutant
[9] were fractionated using RIPA lysis buffer. This method has been de-
scribed previously to separate Gag (Pr55) located in the cytoplasm (sol-
uble fraction) from membrane bound assembly intermediates of Gag
(insoluble fraction) [44]. In agreement with the SPR measurements on
membrane interactions of C-terminal p6 peptides, western blot analy-
ses revealed an increased amount of Gag in the RIPA insoluble fraction
when Ser40 was mutated with Phe (Fig. 5A). Quantiﬁcation of the
band intensities revealed, that the S40F mutation leads to a signiﬁcant
2-fold accumulation of detergent resistant Gag when compared to wt
(Fig. 5B). Of particular importance was the observation that this in-
creased accumulation was only observable for the full length Gag as
all other processing intermediates aswell as capsid p24 and p25 display
no apparent differences in their intracellular distribution. Moreover, if
the N-terminal myristoylation of Gag is impaired by introducing the
G2A mutation in the matrix domain [45] an additional p6 S40F muta-
tion does no longer lead to enhanced amounts of Gag in the membrane
fraction. This demonstrates that p6 is able to modify the membrane
association of Gag, but requires the membrane binding mediated by
matrix. In concordance only full length Gag is affected by this phenom-
enon, since it is the only Gag species containing both, matrix and p6. p6
has previously been identiﬁed as the predominant phosphorylated pro-
tein of HIV-1 particles [8]. More than ten years after its discovery, the
functional importance of phosphorylation of p6 has hitherto not been
clearly deﬁned. According to Müller et al. [8] phosphorylation occurs
shortly before or after the release of p6 from Gag, and involves only a
minor fraction of the total virion-associated p6 molecules. Recently
we reported that mutation of Ser-40 affected CA maturation and virus
core formation, and consequently the infectivity of the released virions,
a function that occurred independently of the L-domain function of the
protein [9]. HIV-1 p6 plays an important role in release of virions from
membranes of infected cells [46], however the S40F mutation did not
affect virus release [9]. The fact that (1) phosphorylation of Ser-40 of
p6 ampliﬁes the interaction of the protein with the cytoplasm mem-
brane and (2) our ﬁndings demonstrating that p6 modulates the
membrane interaction of HIV-1 Gag, could suggest that such post-
translational modiﬁcation of p6may play a role in regulating the timing
of the release of particles from the host cell. Mutation of Ser-40 with
Phe, which eliminates the possibilities of phosphorylation at this posi-
tion of p6, selectively affects CA maturation, virus core formation and
thus infectivity.
4. Conclusions
Even in aqueous solution at pH 7, full-length sp6 exhibits two weak
α-helical domains connected by a ﬂexible hinge region. This secondary
structure becomes more pronounced under hydrophobic conditions
that simulate a native-like environment found inmembranes or the hy-
drophobic surfaces of interacting proteins. The position and stability of
these domains in the protein are very similar in both aqueous 100 mM
DPCmicelles solution and in 50% aqueous TFE. It appears that all identi-
ﬁed functional regions of p6 are associatedwithα-helical regions of the
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Fig. 5. S40Fmutation leads to an enhancedmembrane association of Gag. A)HeLa cells transiently transfectedwith either pΔRwt [43], the p6 S40Fmutant [9], themyristoylationdeﬁcient
matrix G2Amutant [45] or a S40F/G2A doublemutant were fractionated into soluble (sol) and insoluble (ins) fractions using RIPA buffer. Gag proteins were detected bywestern blotting
using anti-p24 antiserum. B) to calculate the ratio of Pr55 in the soluble and insoluble fractions band intensities were quantiﬁed using AIDA (Raytest). Data represent mean values of ﬁve
independent experiments±SD.
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cludes the N-terminal binding domain of p6 to Vpr [24] and is adjacent
to the P7TAPP11 binding motif to Tsg101 [1,2,13,25–30], while the
C-terminal α-helix Ile31-Asp48 includes the binding regions of p6 to
Vpr and ALIX. Under hydrophobic conditions, the C-terminal helix is
even maintained when Ser40, a residue located in the centre of the
helix is phosphorylated.
Most of the known interactions of p6 occur near the cytoplasmic
membrane within the cell. Furthermore, SPR analyses presented in
this paper suggest that p6 interacts directly with the inner leaﬂet of
the cytoplasmicmembranes, which is conﬁrmed by the fact that this in-
teraction is signiﬁcantly magniﬁed when the highly conserved Ser40 is
phosphorylated. Most interestingly, Ser40matches the [ST]-x-[RK] con-
sensus recognitionmotif of protein kinase C (PKC) and thus represents a
potential PKC phosphorylation site. Typically, the activation of PKC en-
zymes mediates their translocation to the plasma or also endosomal
membranes [47–51]. Thus, cell type speciﬁc expression as well as acti-
vation patterns of different PKC isoformsmight support the localization
of Gag to distinct membranes by phosphorylating p6. This could subse-
quently contribute to the targeting of Gag to intracellular budding sites
like it has been previously reported for macrophages [52–55]. The in-
creased hydrophobic interaction of C-terminal p623-52 withmembranes
when substituting Ser-40 with Phe, determined by SPR spectroscopy,
correlated with the observed increased amount of the polyprotein Gag
in the detergent resistant membrane fraction when Ser40 wasmutated
to Phe. Taken together, these data indicate that p6 is able to modulate
themembrane interactions of HIV-1 Gag by either ionic or hydrophobic
interactions.
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